Condition

Small-Cell Lung Cancer (SCLC)

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions6

Lead sponsors shown4

Clinical trials

4 shown

Prospective Multiomic Analysis in Small-Cell Lung CancerNCT07795411 · 2026-11-25

A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung CancerNCT07103408 · 2025-10-01

NOT_YET_RECRUITING

Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based ChemotherapyNCT06736418 · 2025-03-10

ACTIVE_NOT_RECRUITING

Prospective Clinicogenomic ProgramNCT04180176 · 2019-12-13

Common interventions

225Ac-ABD147DRUG1 Biospecimen collectionPROCEDURE1 Blood DrawOTHER1 Consolidative therapyDRUG1 Immuno-chemotherapyDRUG1 RadiotherapyRADIATION1

Leading sponsors

Abdera Therapeutics Inc.1 Genentech, Inc.1 Ohio State University Comprehensive Cancer Center1 Sun Yat-sen University1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

PHASE11

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.